Search

everythinglearnresearchcommunity

for

Search:↓

Innate lymphoid cells help us understand and manage allergic diseases better.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Hair follicle cells can become bone-like cells, useful for bone repair.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Vitamin D is important for skin health and can help treat and prevent various skin conditions.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Many people in Majmaah city, Saudi Arabia, don't know much about vitamin D deficiency and don't practice good vitamin D habits, with few linking it to hair loss.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Certain genes influence immunoglobulin levels in Chinese Holstein cows, which can improve calf health.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.